Keen Vision Acquisition (KVAC) Stock Price, News & Analysis

Company Overview

Keen Vision Acquisition Corp is a Delaware‐incorporated special purpose acquisition company (SPAC) that completed its initial public offering in 2021. Trading on the Nasdaq under the ticker KVAC, the company raised capital through the sale of units priced at $10.00 each. Proceeds from the offering are held in a trust account pending the identification and completion of a business combination.

The company’s principal business activity is to seek a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or assets. While Keen Vision Acquisition has not yet announced a definitive target, it has stated an interest in identifying opportunities in high‐growth sectors such as technology, life sciences and consumer markets. By leveraging its status as a blank‐check vehicle, the firm aims to provide private companies with a public listing and access to additional capital.

Keen Vision Acquisition is sponsored by Keen Vision Capital, an investment firm with experience in private equity and mergers & acquisitions. The management team comprises finance and industry professionals with backgrounds in investment banking, corporate development and strategic advisory services. Though the SPAC is headquartered in the United States, it intends to consider both domestic and international acquisition candidates that can benefit from its capital resources and public company expertise.

Key Stats

• Today's Range: $11.51 to $11.51
• 50-Day Range: $11.32 to $13.38
• 52-Week Range: $11.41 to $18.72
• Volume: N/A
• Average Volume: 14,430 shs
• Market Capitalization: $63.37 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Hold

Keen Vision Acquisition Stock Analysis - MarketRank™

Keen Vision Acquisition scored higher than 29% of companies evaluated by MarketBeat, and ranked 766th out of 912 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.2 / 5
• Analyst Rating: Hold

Consensus Rating

Keen Vision Acquisition has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Keen Vision Acquisition has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: N/A
• Proj. Earnings Growth: N/A

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.25% of the float of Keen Vision Acquisition has been sold short.

Short Interest Ratio / Days to Cover

Keen Vision Acquisition has a short interest ratio ("days to cover") of 0.12, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Keen Vision Acquisition has recently increased by 1,480.35%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Keen Vision Acquisition does not currently pay a dividend.

Dividend Growth

Keen Vision Acquisition does not have a long track record of dividend growth.

News and Social Media

• Score: 2.9 / 5
• News Sentiment: N/A

News Sentiment

Keen Vision Acquisition has a news sentiment score of 1.58. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.57 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Keen Vision Acquisition this week, compared to 1 article on an average week.

Company Ownership

• Score: 1.3 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Keen Vision Acquisition insiders have not sold or bought any company stock.

Percentage Held by Insiders

80.20% of the stock of Keen Vision Acquisition is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

51.72% of the stock of Keen Vision Acquisition is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/14/2026
• Today: 8/19/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Current Symbol: NASDAQ:KVAC
• Previous Symbol: NASDAQ:KVAC
• CIK: 1889983
• Web: www.kv-ac.com
• Phone: 203-609-1394
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 5,506,000
• Free Float: 1,090,000
• Market Cap: $63.37 million
• Optionable: Not Optionable
• Beta: -0.04